These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3795627

  • 1. Further dopaminergic supersensitivity to dopamine agonists by subchronic administration of haloperidol in rats treated with colchicine.
    Kamata K, Okuyama S, Hashimoto S, Aihara H, Kasuya Y.
    Jpn J Pharmacol; 1986 Oct; 42(2):329-32. PubMed ID: 3795627
    [Abstract] [Full Text] [Related]

  • 2. Denervation-like postsynaptic supersensitivity to dopamine agonists induced by microinjection of colchicine into the substantia nigra pars compacta.
    Kamata K, Kameyama T, Okuyama S, Hashimoto S, Aihara H.
    Brain Res; 1986 Mar 05; 367(1-2):1-7. PubMed ID: 3008917
    [Abstract] [Full Text] [Related]

  • 3. Atrophy of the striatum and motor disturbance induced by colchicine.
    Kamata K, Okuyama S, Hashimoto S, Kumura MA, Aihara H, Kasuya Y.
    Brain Res; 1987 Sep 22; 421(1-2):353-7. PubMed ID: 3690277
    [Abstract] [Full Text] [Related]

  • 4. Phencyclidine-induced dopamine-dependent behaviors in chronic haloperidol-treated rats.
    Yamaguchi K, Nabeshima T, Amano M, Yoshida S, Furukawa H, Kameyama T.
    Pharmacol Biochem Behav; 1985 Nov 22; 23(5):803-9. PubMed ID: 4080767
    [Abstract] [Full Text] [Related]

  • 5. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
    Butkerait P, Friedman E.
    Eur J Pharmacol; 1988 Mar 29; 148(2):269-72. PubMed ID: 2897925
    [Abstract] [Full Text] [Related]

  • 6. Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia.
    Gattaz WF, Emrich A, Behrens S.
    J Neural Transm Gen Sect; 1993 Mar 29; 92(2-3):197-201. PubMed ID: 8369109
    [Abstract] [Full Text] [Related]

  • 7. Haloperidol-induced plasma prolactin release: sensitivity, reliability, and comparison to haloperidol antagonism of dopamine agonist-induced stereotyped behavior in the rat.
    Feigenbaum JJ, Moon BH, Catterton R, Yanai J, Klawans HL.
    Psychopharmacology (Berl); 1982 Mar 29; 78(4):383-4. PubMed ID: 6818604
    [No Abstract] [Full Text] [Related]

  • 8. delta 9-Tetrahydrocannabinol elicited ipsilateral circling behavior in rats with unilateral nigral lesion.
    Sakurai Y, Ohta H, Shimazoe T, Kataoka Y, Fujiwara M, Ueki S.
    Life Sci; 1985 Dec 09; 37(23):2181-5. PubMed ID: 2999542
    [Abstract] [Full Text] [Related]

  • 9. Effects of buspirone on dopaminergic supersensitivity.
    Queiroz CM, Frussa-Filho R.
    Life Sci; 1997 Dec 09; 61(4):371-82. PubMed ID: 9244363
    [Abstract] [Full Text] [Related]

  • 10. Chronic nicotine treatment potentiates behavioral responses to dopaminergic drugs in rats.
    Suemaru K, Gomita Y, Furuno K, Araki Y.
    Pharmacol Biochem Behav; 1993 Sep 09; 46(1):135-9. PubMed ID: 7902980
    [Abstract] [Full Text] [Related]

  • 11. Diazepam attenuates the antagonism of haloperidol against apomorphine-induced stereotypic behavior after subchronic but not acute treatment in rats.
    Fuchs V, Coper H, Strauss S, Rommelspacher H.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 09; 334(2):133-7. PubMed ID: 3024028
    [Abstract] [Full Text] [Related]

  • 12. Chronic haloperidol treatment potentiates apomorphine- and ethanol-induced hypothermia in the rat.
    Lai H, Kazi MS, Carino MA, Horita A.
    Life Sci; 1982 Mar 08; 30(10):821-6. PubMed ID: 7200179
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of stereotypy induced by nomifensine in rats during continuous chronic haloperidol treatment.
    Rupniak NM, Jenner P, Marsden CD.
    Neurosci Lett; 1984 Sep 07; 50(1-3):63-5. PubMed ID: 6541767
    [Abstract] [Full Text] [Related]

  • 14. Effects of melatonin on behavioral dopaminergic supersensitivity.
    Abílio VC, Vera JA, Ferreira LS, Duarte CR, Martins CR, Torres-Leite D, Ribeiro Rde A, Frussa-Filho R.
    Life Sci; 2003 May 16; 72(26):3003-15. PubMed ID: 12706487
    [Abstract] [Full Text] [Related]

  • 15. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR.
    Neuropsychobiology; 2003 May 16; 24(2):102-8. PubMed ID: 2151972
    [Abstract] [Full Text] [Related]

  • 16. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N, Dall'Olio R, Gandolfi O, Vaccheri A.
    Eur J Pharmacol; 1982 Jun 16; 81(1):1-9. PubMed ID: 6889533
    [Abstract] [Full Text] [Related]

  • 17. Effects of apomorphine administration on rearing activity of control and experimental rats withdrawn from long-term haloperidol treatment.
    Bernardi MM, Palermo-Neto J.
    Gen Pharmacol; 1984 Jun 16; 15(4):363-5. PubMed ID: 6541605
    [Abstract] [Full Text] [Related]

  • 18. Genotypic influences on striatal dopaminergic regulation in mice.
    Severson JA, Randall PK, Finch CE.
    Brain Res; 1981 Apr 06; 210(1-2):201-15. PubMed ID: 6261873
    [Abstract] [Full Text] [Related]

  • 19. Reduction of dopaminergic supersensitivity by a single dose of amphetamine.
    Haracz JL, Tseng LF.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug 06; 313(2):131-3. PubMed ID: 6106902
    [Abstract] [Full Text] [Related]

  • 20. Behavioural subsensitivity induced by long-term administration of a low dose of haloperidol to rats.
    Frussa-Filho R, Abílio VC, Bergamo M, Palermo-Neto J.
    J Pharm Pharmacol; 1997 Apr 06; 49(4):412-5. PubMed ID: 9232539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.